Marksans Pharma Limited (NSE:MARKSANS)
India
· Delayed Price · Currency is INR 226.05
-6.64 (-2.85%)
Feb 21, 2025, 3:30 PM IST
Marksans Pharma Employees
Marksans Pharma had 1,141 employees as of March 31, 2024. The number of employees increased by 289 or 33.92% compared to the previous year.
Employees
1,141
Change (1Y)
289
Growth (1Y)
33.92%
Revenue / Employee
21.69M INR
Profits / Employee
3.23M INR
Market Cap
102.44B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1,141 | 289 | 33.92% |
| Mar 31, 2023 | 852 | -38 | -4.27% |
| Mar 31, 2022 | 890 | -248 | -21.79% |
| Mar 31, 2021 | 1,138 | -12 | -1.04% |
| Mar 31, 2020 | 1,150 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 9,741 |
| Cipla | 27,764 |
| Mankind Pharma | 19,540 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 26,921 |
| Aurobindo Pharma | 26,015 |
| Alkem Laboratories | 17,432 |
Marksans Pharma News
- 3 months ago - Marksans Pharma shares jump 2% following USFDA approval for Loratadine Tablets USP 10 mg - Business Upturn
- 3 months ago - Marksans Pharma receives USFDA approval for Loratadine Tablets USP 10 mg - Business Upturn
- 3 months ago - Marksans Pharma Ltd (BOM:524404) Q2 FY25 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 3 months ago - Marksans Pharma shares jump over 3% on Q2 results - Business Upturn
- 3 months ago - Marksans Pharma Q2 FY25: Revenue up 20.84% YoY to Rs 641.92 crore, Net Profit up 16.56% YoY - Business Upturn
- 3 months ago - Marksans Pharma Q2 FY25 results: Stock surge over 3% ahead of result announcement - Business Upturn